Sanas Receives Frost & Sullivan’s 2025 North American Company of the Year Recognition for Leadership in Accent Translation Solutions
Commitment to inclusivity, innovation, and customer experience positions Sanas as a category-defining…
The National Geographic Society and PepsiCo Launch New Food for Tomorrow Program Focused on Regenerative Agriculture
WASHINGTON, Sept. 4, 2025 /PRNewswire/ -- Today, the National Geographic Society and…
Trump-Backed WLFI Lists on HTX, Paving the Way for Inclusive and Compliant Finance
PANAMA CITY, Sept. 4, 2025 /PRNewswire/ -- World Liberty Financial (WLFI), a…
Starburst Announces AI & Datanova 2025, the Global Virtual Summit for Trino, Data and AI Innovation
On October 22–23, Starburst brings together innovators shaping the next wave of…
Fitterfly Launches ‘Uplift’ – A Mental Wellness Program for Students and Communities
MUMBAI, India, Sept. 4, 2025 /PRNewswire/ -- A recent national study across nine…
Enfinity Global Secures 316 Million Financing for 276 MW of Solar Projects in Italy
MILAN, Sept. 4, 2025 /PRNewswire/ -- Enfinity Global Inc., a leading renewable…
Neo4j Launches Infinigraph: The Most Scalable Graph Database for Unified Operational and Analytical Workloads at 100TB+ Scale
New architecture fuses real-time transactions and analytics in one platform, with breakthrough…
Office Beacon Marks Global Talent Acquisition Day with Bold Call for Borderless Hiring
LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- On Global Talent Acquisition Day, Office…
Swiggy expands ‘Campus Streaks’- A new initiative that provides a Fun Way for College Students to Order and Win Together
BENGALURU, India, Sept. 3, 2025 /PRNewswire/ -- Swiggy (Swiggy Ltd), (NSE: SWIGGY)…
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and…
